Hydroxyethyl starch for fluid resuscitation fared poorly in two recent meta-analyses involving critically ill patients. ... 15 by BMJ. Rivaroxaban is noninferior to enoxaparin for standard-duration venous thromboembolism (VTE) prophylaxis in acutely ill
Public reporting on hospital quality via the Hospital Compare website had minimal impact on mortality rates for three key conditions, a recent study found. ... The American Association of Blood Banks (AABB) recommends a restrictive red blood cell
Krein said. Even when hospitals do provide training, recent research from Dr. ... Krein, also a research career scientist at the VA Ann Arbor Healthcare System.
Rates and causes of hospital readmissions, and the infrequency of follow-up care, were quantified in a research brief from the National Institute for Health Care Reform. ... The authors called for additional research on effective care for high-risk
But recent research has proven that such calculations may be vulnerable to racial bias. ... But I don't think our research should be interpreted as an indictment of algorithms in health care.
Troponin T levels independently predict 30-day mortality after noncardiac surgery, a recent study found. ... Existing tools to predict 30-day mortality, which also have been recommended to identify patients for ICU admission, have been shown in recent
0.6% of controls; adjusted rate ratio [ARR], 4.50). Neither recent use (0.3% of cases vs. ... Thrombolytic therapy improves mortality in unstable patients with acute pulmonary embolism (PE) but is underused, according to a recent study.
routinely in patients outside of the intensive care unit, a recent study concluded. ... Automatic referral combined with a clinician discussion can increase patients' use of cardiac rehabilitation after hospital discharge, recent research suggests.
Although the CAM-ICU has high sensitivity and specificity when administered by research nurses, its performance in day-to-day practice is unknown. ... Greater blood loss from phlebotomy is associated with higher risk of anemia in patients hospitalized
An accompanying editorial noted that another recent trial of a tele-ICU found no benefit to the intervention. ... Further research is needed to determine definitively whether use of the STOPP criteria reduces adverse events, medication costs and health